布洛芬作为结合竞争剂增强血液透析对蛋白结合尿毒症毒素的清除
本研究在18例维持性血液透析患者中,于常规4小时高通量透析的第21至40分钟向动脉血路输注800 mg布洛芬,发现吲哚硫酸和对甲酚硫酸的清除率及透析液浓度显著增加,而尿素和肌酐清除未受影响,表明布洛芬可竞争性置换白蛋白结合位点以增强蛋白结合毒素的清除。
要点
- 透析中输注布洛芬可显著提高吲哚硫酸和对甲酚硫酸的清除率。
- 布洛芬输注不增加尿素和肌酐等非蛋白结合溶质的清除。
- 该策略为清除蛋白结合尿毒症毒素提供了新思路。
核心结论
- 透析中输注布洛芬可显著增加吲哚硫酸和对甲酚硫酸的清除并降低其血清水平。
研究设计与样本
- 在18例维持性血液透析患者中,于常规4小时高通量透析的第21至40分钟向动脉血路输注800 mg布洛芬,测量透析前后及过程中多种溶质浓度。
主要发现
- 吲哚硫酸清除率中位数从6.0 ml/min升至20.2 ml/min,对甲酚硫酸从4.4 ml/min升至14.9 ml/min(各P<0.001)。
- 透析液出口蛋白结合毒素相对水平中位数从1.0(参考)分别升至2.4(吲哚硫酸)和2.4(对甲酚硫酸)(各P<0.001)。
- 输注后透析器后血清吲哚硫酸和对甲酚硫酸水平分别下降1.0和0.3 mg/dl(各P<0.001)。
- 尿素和肌酐的清除未因布洛芬输注而增加。
临床怎么用
- 布洛芬输注可作为增强蛋白结合尿毒症毒素清除的潜在辅助手段,但需进一步评估安全性和长期获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Current hemodialysis techniques fail to efficiently remove the protein-bound uremic toxins p-cresyl sulfate and indoxyl sulfate due to their high degree of albumin binding. Ibuprofen, which shares the same primary albumin binding site with p-cresyl sulfate and indoxyl sulfate, can be infused during hemodialysis to displace these toxins, thereby augmenting their removal. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We infused 800 mg ibuprofen into the arterial bloodline between minutes 21 and 40 of a conventional 4-hour high-flux hemodialysis treatment. We measured arterial, venous, and dialysate outlet concentrations of indoxyl sulfate, p-cresyl sulfate, tryptophan, ibuprofen, urea, and creatinine before, during, and after the ibuprofen infusion. We report clearances of p-cresyl sulfate and indoxyl sulfate before and during ibuprofen infusion and dialysate concentrations of protein-bound uremic toxins normalized to each patient's average preinfusion concentrations. RESULTS: We studied 18 patients on maintenance hemodialysis: age 36±11 years old, ten women, and mean vintage of 37±37 months. Compared with during the preinfusion period, the median (interquartile range) clearances of indoxyl sulfate and p-cresyl sulfate increased during ibuprofen infusion from 6.0 (6.5) to 20.2 (27.1) ml/min and from 4.4 (6.7) to 14.9 (27.1) ml/min (each P<0.001), respectively. Relative median (interquartile range) protein-bound uremic toxin dialysate outlet levels increased from preinfusion 1.0 (reference) to 2.4 (1.2) for indoxyl sulfate and to 2.4 (1.0) for p-cresyl sulfate (each P<0.001). Although median serum post- and predialyzer levels in the preinfusion period were similar, infusion led to a marked drop in serum postdialyzer levels for both indoxyl sulfate and p-cresyl sulfate (-1.0 and -0.3 mg/dl, respectively; each P<0.001). The removal of the nonprotein-bound solutes creatinine and urea was not increased by the ibuprofen infusion. CONCLUSIONS: Infusion of ibuprofen into the arterial bloodline during hemodialysis significantly increases the dialytic removal of indoxyl sulfate and p-cresyl sulfate and thereby, leads to greater reduction in their serum levels.
引用
- Madero M, Cano KB, Campos I, et al. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor. Clin J Am Soc Nephrol. 2019. PMID: 30755453. doi:10.2215/CJN.05240418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。